| FPBFX | TRZYX | FPBFX / TRZYX | |
| Total Expense Ratio | 0.98 | 0.00 | - |
| Annual Report Gross Expense Ratio | 0.98 | 1.16 | 84% |
| Fund Existence | 40 years | 5 years | - |
| Gain YTD | 26.923 | 7.661 | 351% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.28B | 450M | 283% |
| Annual Yield % from dividends | 3.41 | 4.33 | 79% |
| Returns for 1 year | 40.97 | 20.97 | 195% |
| Returns for 3 years | 82.78 | 28.48 | 291% |
| Returns for 5 years | 23.82 | 27.76 | 86% |
| Returns for 10 years | 100.26 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XMVM | 71.43 | 0.65 | +0.92% |
| Invesco S&P MidCap Value with Momt ETF | |||
| AQEC | 24.64 | N/A | +0.01% |
| AQE Core ETF | |||
| BIB | 98.28 | N/A | N/A |
| ProShares Ultra Nasdaq Biotechnology | |||
| LVHI | 41.11 | -0.05 | -0.12% |
| Franklin Intl Low Volatility Hi Div ETF | |||
| WNTR | 27.95 | -0.32 | -1.13% |
| YieldMax MSTR Short Option Income Strategy ETF | |||